ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

DePinho Explains Tenure Decision,Professors Dispute Key Details

May 30, 2014

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search

June 22, 1984